Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al

Ann Rheum Dis. 2019 Nov 19;annrheumdis-2019-216557. doi: 10.1136/annrheumdis-2019-216557. Online ahead of print.
No abstract available

Keywords: TNF-alpha; anti-TNF; disease activity; rheumatoid arthritis; treatment.

Publication types

  • Letter